PERIOGARD MOUTHWASH

Kraj: Kanada

Język: angielski

Źródło: Health Canada

Składnik aktywny:

CHLORHEXIDINE GLUCONATE

Dostępny od:

COLGATE-PALMOLIVE CANADA INC

Kod ATC:

A01AB03

INN (International Nazwa):

CHLORHEXIDINE

Dawkowanie:

0.12%

Forma farmaceutyczna:

MOUTHWASH

Skład:

CHLORHEXIDINE GLUCONATE 0.12%

Droga podania:

BUCCAL

Sztuk w opakowaniu:

473ML

Typ recepty:

Prescription

Dziedzina terapeutyczna:

MISCELLANEOUS ANTI-INFECTIVES

Podsumowanie produktu:

Active ingredient group (AIG) number: 0107629007; AHFS:

Status autoryzacji:

CANCELLED POST MARKET

Data autoryzacji:

2022-03-30

Charakterystyka produktu

_Page 1 of 19_
PRODUCT MONOGRAPH
CHLORHEXIDINE GLUCONATE ORAL RINSE
Chlorhexidine Gluconate 0.12% Oral Rinse Liquid, USP
0.12% Chlorhexidine Gluconate Antigingivital Oral Rinse
Colgate-Palmolive Canada Inc.
Two Morneau Shepell Centre, 5
th
Floor,
895 Don Mills Road,
Toronto, Ontario
M3C 1W3
Submission Control No.: 207101
Date of Preparation:
August 17, 2017
_Page 2 of 19_
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL
INFORMATION.....................................................3
SUMMARY PRODUCT INFORMATION
................................................................3
INDICATIONS AND CLINICAL USE
......................................................................3
CONTRAINDICATIONS
.........................................................................................3
WARNINGS AND PRECAUTIONS
........................................................................4
ADVERSE
REACTIONS.........................................................................................6
DOSAGE AND ADMINISTRATION
........................................................................6
OVERDOSAGE
.....................................................................................................7
ACTION AND CLINICAL PHARMACOLOGY
........................................................8
STORAGE AND STABILITY
..................................................................................9
SPECIAL HANDLING INSTRUCTIONS
................................................................9
DOSAGE FORMS, COMPOSITION AND PACKAGING
.....................................10
PART II: SCIENTIFIC INFORMATION
..........................................................................11
PHARMACEUTICAL
INFORMATION..................................................................11
CLINICAL TRIALS
................................................................................................12
DETAILED PHARMACOLOGY
............................................................................13
MICROBIOLOGY
..............................